Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03099343 · ClinicalTrials.gov registry record · NA
Tailored Messaging to Reduce Sodium Intake
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT03099343 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 50 participants.
The verdict
NCT03099343, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The proposed study will determine the effectiveness of a mobile application location-based tailored notification message system in helping hypertensive patients reduce dietary sodium intake and feel more confident in following a low sodium diet.
Interventions
- BEHAVIORAL Location-based Tailored Messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-09-21 |
| Est. Completion | 2019-04-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03099343
The ClinicalTrials.gov registry entry for NCT03099343 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Location-based Tailored Messaging is the first listed.
NCT03099343 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03099343 about?
NCT03099343 is a clinical study titled "Tailored Messaging to Reduce Sodium Intake". The proposed study will determine the effectiveness of a mobile application location-based tailored notification message system in helping hypertensive patients reduce dietary sodium intake and feel more confident in following a low sodium diet.
What is the current status of trial NCT03099343?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-09-21. Estimated completion is 2019-04-26.
What interventions are being tested in trial NCT03099343?
The interventions under investigation include: Location-based Tailored Messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT03099343?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.